Bacterial 70S ribosome — Drug Target
All drugs that target Bacterial 70S ribosome — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- TR-701 FA · Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · Oxazolidinone antibiotic · Infectious Disease
TR-701 FA is a prodrug of TR-700 that inhibits bacterial protein synthesis by binding to the bacterial ribosome.